Feasibility of Catalpol Intranasal Administration and Its Protective Effect on Acute Cerebral Ischemia in Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms
Jinghui Wang,Yuhua Zhang,Meifeng Zhang,Si Sun,Yang Zhong,Lei Han,Yitong Xu,Dong Wan,Junhui Zhang,Huifeng Zhu
DOI: https://doi.org/10.2147/DDDT.S343928
2022-01-25
Abstract:Jinghui Wang, 1 Yuhua Zhang, 2 Meifeng Zhang, 1 Si Sun, 1 Yang Zhong, 1 Lei Han, 1 Yitong Xu, 1 Dong Wan, 3 Junhui Zhang, 4 Huifeng Zhu 1 1 College of Pharmaceutical Sciences & College of Chinese Medicine, Southwest University, Chongqing, 400715, People's Republic of China; 2 Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, 445000, People's Republic of China; 3 Department of Emergency and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China; 4 Health Management Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China Correspondence: Huifeng Zhu College of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing, 400715, People's Republic of China Email Junhui Zhang Health Management Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China Email Purpose: Catalpol is the main active component of Rehmannia glutinosa, which has a variety of pharmacological activities, including anti-inflammatory and anti-oxidative effects. This study investigates the feasibility of catalpol intranasal administration and its protective effect on acute cerebral ischemia in rats via anti-oxidative and anti-apoptotic mechanisms. Patients and Methods: This study investigates the method of catalpol intranasal administration to evaluate the nasal mucosal toxicity, brain targeting and pharmacokinetics of catalpol. The protective effect of catalpol of intranasal administration on stroke-induced brain injury in rats and its mechanisms on oxidative stress pathway Nrf2/HO-1 and apoptosis were also investigated using middle cerebral artery occlusion (MCAO). Results: The results showed that catalpol intranasal administration was safe and feasible with no hemolysis, no bad effect on the maxillary ciliary movement of bullfrog. After intranasal administration, the brain targeting index (DTI) of catalpol was greater than 1, which indicated that catalpol had good brain targeting after intranasal administration. The bioavailability of catalpol administered intranasally was higher than that of in plasma. In MACO model, catalpol intranasal administration could significantly reduce cerebral infarction volume, neurological dysfunction and brain edema. In addition, catalpol intranasal administration can also reduce the brain cell's occurrence of apoptosis, promote the expression of Bcl-2 protein and inhibit the expression of Bax protein, reduce oxidative stress damage via up-regulating expression of Nrf2 and HO-1, increasing the activities of SOD and decreasing the activities of MDA. Conclusion: Collectively, catalpol intranasal administration has good safety, stability and brain targeting. It can effectively protect the brain injury of the rat model of acute cerebral ischemia and provide the possibility of drug administration in the acute stage of cerebral ischemia, especially before entering the hospital. Keywords: catalpol, cerebral ischemia, intranasal administration, oxidative stress, apoptosis, neuroprotection Graphical Stroke is the most common neurological disease with high morbidity, mortality and disability. 1 Stroke can be divided into ischemic and hemorrhagic, of which 85% is ischemic stroke. 2 Early use of drug in acute phase is the key to the treatment of ischemic stroke. 3 Cerebral ischemia patients in a short period of time are very likely to appear on one side hemiplegia, aphasia, more serious coma or death. 4 Because the onset of cerebral ischemia is urgent, the attack is not predictable, and the disability rate and mortality rate are high, rapid control is the key to treatment. After cerebral ischemia, there will be disturbance of consciousness and difficulty in swallowing. The traditional way of administration such as via intravenous injection or to be taken orally have disadvantage. For example, intravenous injections need to be done in hospital; Drug taken orally is dangerous because these stroke patients are often in the state of disturbance of consciousness. So the intranasal administration has the advantages of convenient operation, rapid absorption and quick effect, and can quickly transmit the drug to the brain to facilitate first aid and self-rescue. Cerebral ischemia injury is a complex pathophysiological process. 5 Cerebral blood flow disruption causes brain tissue ischemia and hypoxia, oxidative stress injury, inflammatory response and apoptosis, whi -Abstract Truncated-